Those pushing for a statewide program to help those who can’t afford insulin could have a tougher sell at the Minnesota Legislature — that after UCare became the second Minnesota insurer to cap monthly out-of-pocket insulin costs for its members. Advocates at the State Capitol yesterday (Wed) argued drug companies’ patient assistance programs are inadequate:
“More than 42 percent of those who apply to these charity programs that these pharma folk programs offer are denied.”
…Nicole Smith-Holt. But Senate Republican leaders argue patients’ out-of-pocket costs for insulin appear to be dropping due to H-M-O policy changes in a market stabilized by the state’s “reinsurance” program.